(Reuters) - The FDA last month approved Wyeth's birth control pill
Lybrel and its drug Torisel for patients with an advanced form
of kidney cancer.
Moody's currently rates Wyeth's senior unsecured debt "A3,"
its seventh-highest investment-grade rating.
Read more at Reuters.com Bonds News
Lybrel and its drug Torisel for patients with an advanced form
of kidney cancer.
Moody's currently rates Wyeth's senior unsecured debt "A3,"
its seventh-highest investment-grade rating.
Read more at Reuters.com Bonds News
No comments:
Post a Comment